Catalyst Wire Dossier Catalyst Wire Dossier

AIV001

· AiViva BioPharma, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AIV001, covering 2024-12-24 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy [Phase 1]

See pricing